Naor


Rapid Diagnostic Systems specializes in decentralized rapid RNA diagnosis of COVID-19 and other pathogens, with a focus on innovative, scalable, and easy-to-use testing solutions. Their platform, NaorCov19, offers rapid, saliva-based molecular diagnostics that are suitable for various settings including workplaces, airports, schools, and homes. The company emphasizes technological advancement, collaboration with research institutions like the Technion, and aims to make testing accessible and efficient worldwide.

Industries

health-diagnostics
medical

Nr. of Employees

small (1-50)

Naor

Haifa, Hefa, Israel, Asia


Products

Saliva-based rapid molecular diagnostic kit

A kit for decentralized molecular detection of RNA targets using direct saliva sampling, isothermal amplification, and colorimetric readout to provide results on-site within approximately one hour.

Disposable saliva collection device and low-cost incubator

Single-use saliva collection consumable designed for compatibility with the extraction-free assay and paired with inexpensive heating devices for sample incubation.

Cloud-integrated test documentation and reporting system

Digital platform for documenting sample collection, tracking results, and notifying stakeholders via cloud services and SMS.


Services

On-site implementation of high-throughput, decentralized testing workflows for institutions and transport settings to enable regular surveillance and screening.

Conducting clinical evaluations and performance studies using biobank and patient-collected samples to assess assay sensitivity and operational characteristics.

Partnerships with academic labs, medical centers and government R&D organizations for co-development, testing and scale-up of molecular diagnostic assays.

Expertise Areas

  • Decentralized molecular diagnostics
  • Point-of-care testing and surveillance
  • Clinical validation and sample-based performance evaluation
  • Isothermal nucleic acid amplification methods
  • Show More (4)

Key Technologies

  • RT-LAMP (reverse-transcribed loop-mediated isothermal amplification)
  • Colorimetric assay chemistry
  • RNA extraction–free protocols
  • Saliva-based sampling
  • Show More (4)

News & Updates

Rapid Diagnostic Systems announced that their NaorCov-19 test received CE European Conformity Mark approval, enabling sales across the European Union and other CE-marked regions.

The Technion conducted extensive rapid COVID-19 testing using NaorCov19, aiding in health protection and outbreak control.

A new rapid COVID-19 test developed by Technion, using NaorCov19 technology, offers results in under an hour and is suitable for various settings.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.